BlackRock’s iShares Evolved U.S. Innovative Healthcare ETF IEIH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10,000
| Closed | -$329K | – | 6022 |
|
|
2022
Q2 | $329K | Hold |
10,000
| – | – | ﹤0.01% | 4899 |
|
|
2022
Q1 | $342K | Hold |
10,000
| – | – | ﹤0.01% | 4976 |
|
|
2021
Q4 | $355K | Hold |
10,000
| – | – | ﹤0.01% | 4976 |
|
|
2021
Q3 | $351K | Hold |
10,000
| – | – | ﹤0.01% | 4851 |
|
|
2021
Q2 | $350K | Hold |
10,000
| – | – | ﹤0.01% | 4781 |
|
|
2021
Q1 | $323K | Hold |
10,000
| – | – | ﹤0.01% | 4664 |
|
|
2020
Q4 | $324K | Hold |
10,000
| – | – | ﹤0.01% | 4408 |
|
|
2020
Q3 | $303K | Hold |
10,000
| – | – | ﹤0.01% | 4342 |
|
|
2020
Q2 | $299K | Sell |
10,000
-40,000
| -80% | -$1.15M | ﹤0.01% | 4299 |
|
|
2020
Q1 | $1.27M | Sell |
50,000
-20,000
| -29% | -$540K | ﹤0.01% | 3804 |
|
|
2019
Q4 | $1.96M | Hold |
70,000
| – | – | ﹤0.01% | 3800 |
|
|
2019
Q3 | $1.7M | Sell |
70,000
-70,000
| -50% | -$1.74M | ﹤0.01% | 3810 |
|
|
2019
Q2 | $3.57M | Buy |
140,000
+40,000
| +40% | +$1M | ﹤0.01% | 3614 |
|
|
2019
Q1 | $2.6M | Sell |
100,000
-35,000
| -26% | -$892K | ﹤0.01% | 3616 |
|
|
2018
Q4 | $3.18M | Sell |
135,000
-15,000
| -10% | -$377K | ﹤0.01% | 3531 |
|
|
2018
Q3 | $4.11M | Buy |
+150,000
| New | +$3.96M | ﹤0.01% | 3558 |
|
|
2018
Q2 | – | Sell |
-150,000
| Closed | -$3.58M | – | 5116 |
|
|
2018
Q1 | $3.58M | Buy |
+150,000
| New | +$3.59M | ﹤0.01% | 3522 |
|
BlackRock's IEIH Position: Q3 2022 in Review
BlackRock sold out of iShares Evolved U.S. Innovative Healthcare ETF (IEIH) in Q3 2022, closing a stake of 10,000 shares — an estimated $329K sold.
BlackRock first reported a position in IEIH in Q1 2018 and held it in 17 quarters. The position peaked at $4.11M in Q3 2018. 0 funds tracked by Wall St. Rank hold IEIH as of Q3 2022.
- BlackRock reported no remaining iShares Evolved U.S. Innovative Healthcare ETF position as of Q3 2022 after selling out during the quarter.
- BlackRock sold 10,000 iShares Evolved U.S. Innovative Healthcare ETF shares in Q3 2022, an estimated $329K.
- BlackRock first reported a position in iShares Evolved U.S. Innovative Healthcare ETF in Q1 2018 and held it in 17 quarters.
- BlackRock's iShares Evolved U.S. Innovative Healthcare ETF position peaked at $4.11M in Q3 2018.
- 0 funds tracked by Wall St. Rank held iShares Evolved U.S. Innovative Healthcare ETF as of Q3 2022.
Based on BlackRock's 13F filing for Q3 2022, filed 14 Nov 2022.